IL6 and metabolic syndrome: The observed downregulation of IL-6 in the subcutaneous but not the perirenal fat of the MetS + RAS group may be secondary to the depot-dependence of IL-6 release [38], as both its release and activity differ between visceral and subcutaneous fat [39].